Detalles de la búsqueda
1.
Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T grid.
Opt Express
; 23(12): 16196-208, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26193592
2.
Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
Cancer Res
; 55(2): 440-3, 1995 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-7529139
3.
PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
Cancer Res
; 54(16): 4508-15, 1994 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-7519122
4.
Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment.
Cancer Res
; 50(18): 5795-800, 1990 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-2118421
5.
Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARalpha fusion protein.
Leukemia
; 12(4): 563-70, 1998 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-9557615
6.
Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium.
Eur J Cancer
; 28A(4-5): 818-25, 1992.
Artículo
en Inglés
| MEDLINE | ID: mdl-1524901
7.
Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinoma.
Eur J Cancer
; 26(11-12): 1152-6, 1990.
Artículo
en Inglés
| MEDLINE | ID: mdl-2149997
8.
Fluctuations of plasma beta 2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells.
Immunobiology
; 178(4-5): 305-15, 1989 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-2497064
9.
Long-term culture growth of CD4-CD8- lymphocytes exhibiting elevated non-MHC-restricted cytotoxic activity.
J Biol Regul Homeost Agents
; 5(1): 10-8, 1991.
Artículo
en Inglés
| MEDLINE | ID: mdl-1715635
10.
The synergistic effect of simultaneous addition of retinoic acid and vitamin D3 on the in-vitro differentiation of human promyelocytic leukemia cell lines could be efficiently transposed in vivo.
Med Hypotheses
; 50(3): 253-7, 1998 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-9578330
11.
Interleukin 2 in cancer therapy.
Ann Ist Super Sanita
; 26(3-4): 283-334, 1990.
Artículo
en Inglés
| MEDLINE | ID: mdl-2091501
12.
Design, recruitment, logistics, and data management of the GEHA (Genetics of Healthy Ageing) project.
Exp Gerontol
; 46(11): 934-45, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21871552
13.
High dose-intense chemotherapy alone or in combination with interleukin-2 for small cell lung cancer: a pilot study.
Cancer Invest
; 12(6): 574-87, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7994592
14.
Combined vitamin D3/retinoic acid induction of human promyelocytic cell lines: enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype.
Cell Growth Differ
; 6(5): 493-503, 1995 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-7647032
15.
Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines.
J Immunol
; 150(6): 2418-30, 1993 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-8383719
16.
Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotype.
Cancer Immunol Immunother
; 31(1): 11-8, 1990.
Artículo
en Inglés
| MEDLINE | ID: mdl-2306752
17.
Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors.
Blood
; 88(9): 3391-406, 1996 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-8896404
Resultados
1 -
17
de 17
1
Próxima >
>>